2025 annual financial data
Kyntra Bio 2025 Operating margin
Kyntra Bio 2025 operating margin with verified reported values.
Direct answer
Operating margin was -712.66%.
Operating income was -45,895,000 USD and net income was 183,452,000 USD.
Operating cash flow was -4,774,000 USD.
Get free Kyntra Bio email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 6,440,000 USD
- Operating income
- -45,895,000 USD
- Net income
- 183,452,000 USD
- Operating cash flow
- -4,774,000 USD